Mazor Robotics Ltd, of Caesarea, Israel, reports that surgeons have successfully completed the 10, 000th spinal surgery using the Mazor Robotics guidance system. The company launched the system in 2012
Mazor Robotics Treats 10, 000th Patient

Company officials assert that Renaissance participates in a wide variety of spine procedures, including minimally invasive and percutaneous degenerative repair, vertebrae stabilization and fixation for complex spinal deformity as well as vertebral augmentation. To date, Renaissance has been used in over 1, 000 complex spinal deformity correction procedures and has been used in a variety of brain operations, including deep brain stimulation procedures. The youngest patient to be operated on using Renaissance was five years old and the oldest patient was 92 years old.
“I have been incorporating Mazor Robotics technology into my practice for over five years now, ” said pediatric orthopedic surgeon Dennis Devito, M.D., of Children’s Orthopedics of Atlanta. He said, “I find it provides improved patient care through enhancement of the surgeon’s capabilities. As a surgeon that has many patients with severe spinal deformity, the Renaissance Guidance System allows me to visualize and plan my surgery so I can focus my attention on correcting my patients’ curve.”
“As we approach 50 Renaissance Guidance Systems in the U.S., our goal is to accelerate the adoption of the system, to make it the standard of care for spinal surgeons across the country, ” said Mazor Robotics CEO Ori Hadomi. “While we are very proud of the tools we have built for the surgeons using Renaissance, what is most rewarding for the team at Mazor is to see the way our system enables patients to quickly get back on their feet and resume their daily activities, a reality that many would have thought impossible only a few years ago.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.